Vimarsana
Biggest News Aggregation in the World

Page 50 - Multiple System Atrophy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple System Atrophy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple System Atrophy Today - Breaking & Trending Today

Fundraiser set for former McSherrystown cop - Vimarsana News

Fundraiser set for former McSherrystown cop

A fundraiser involving a former McSherrystown Police Department officer, Chad Sprankle, is set for Saturday.

Inhibikase Therapeutics to Report Full Year 2021 Financial Results on March 31, 2022 - Vimarsana News

Inhibikase Therapeutics to Report Full Year 2021 Financial Results on March 31, 2022

/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course...

Inhibikase Therapeutics to Participate in the Maxim Group 2022 Virtual Growth Conference - Vimarsana News

Inhibikase Therapeutics to Participate in the Maxim Group 2022 Virtual Growth Conference

/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course...

AC Immune Reports First Live Images of Alpha-Synuclein in - Vimarsana News

AC Immune Reports First Live Images of Alpha-Synuclein in

ACI-12589 distinguished multiple system atrophy (MSA) from other a-synucleinopathies and healthy volunteers A-syn PET tracers may be developed to diagnose...

AC Immune Reports First Live Images of Alpha-Synuclein in Human Brain with New PET Tracer for Neurodegenerative Disease at AD/PDTM Conference - Vimarsana News

AC Immune Reports First Live Images of Alpha-Synuclein in Human Brain with New PET Tracer for Neurodegenerative Disease at AD/PDTM Conference

ACI-12589 distinguished multiple system atrophy (MSA) from other a-synucleinopathies and healthy volunteers A-syn PET tracers may be developed to diagnose a-synuclein pathologies, including Parkinson’...